We sought to design ubiquitin-proteasome system inhibitors active against solid cancers by targeting ubiquitin receptor RPN13 within the proteasome's 19S regulatory particle. The …
RK Anchoori, L George, SH Tseng, B Lam… - Plos one, 2021 - journals.plos.org
Bortezomib and the other licensed 20S proteasome inhibitors show robust activity against liquid tumors like multiple myeloma, but have disappointed against solid tumors including …
A Mdzinarishvili, H Houson, A Hedrick, V Awasthi - Brain Injury, 2022 - Taylor & Francis
Objectives Revascularization is necessary in patients with ischemic stroke, however it does not address inflammation that contribute to reperfusion injury and the early growth of …
Intestinal ischemic-reperfusion injury (IRI) occurs when vascular blood flow is interrupted in the mesenteric vessels, followed by reperfusion when blood flow is re-established to the …
Selective killing of cancer cells by chemotherapy has been an age old challenge, but certain unique features of cancer cells allow discriminatory response between cancer and normal …
C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double …